Pathologic Complete Response of HER-2 Neu-Positive Invasive Ductal Carcinoma and Ductal Carcinoma In Situ following Neoadjuvant Chemotherapy plus Trastuzumab: A Case Report and Review of Literature
Figure 1
Comparison of mammographic studies before and after neoadjuvant chemotherapy. (a) Right MLO view prior to neoadjuvant chemotherapy. The blue arrow indicates the mass with surrounding microcalcifications. The yellow arrows indicate additional malignant-appearing microcalcifications occupying the upper part of the right breast. (b) Right MLO view after neoadjuvant chemotherapy. The blue arrow shows resolution of the mass but persistence of surrounding microcalcifications. The yellow arrows show persistence of the additional, extensive microcalcifications. (c) Right CC view prior to neoadjuvant chemotherapy. The yellow arrows indicate the areas of microcalcifications. The blue arrow indicates the breast mass. (d) Right CC view after neoadjuvant chemotherapy. The yellow arrows indicate the areas of persistent microcalcifications. The blue arrow shows complete resolution of the breast mass.
